EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains

Fanny Saidoune iD, Danyel Lee iD, Jeremy Di Domizio iD, Corentin Le Floc'h iD, Raphael Jenelten iD, Jérémie Le Pen iD, Vincent Bondet iD, Ana Joncic iD, Marie-Anne Morren iD, Vivien Béziat iD, Shen-Ying Zhang iD, Emmanuelle Jouanguy iD und 7 weitere

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20231467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Fanny Saidoune und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, CHUV University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Interferon Type I, Chilblains, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Academy of Dermatology and Venereology, Schlumberger Foundation, French Foundation for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outbreaks of chilblains were reported during the COVID-19 pandemic. Given the essential role of type I interferon (I-IFN) in protective immunity against SARS-CoV-2 and the association of chilblains with inherited type I interferonopathies, we hypothesized that excessive I-IFN responses to SARS-CoV-2 might underlie the occurrence of chilblains in this context. We identified a transient I-IFN signature in chilblain lesions, accompanied by an acral infiltration of activated plasmacytoid dendritic cells (pDCs). Patients with chilblains were otherwise asymptomatic or had mild disease without seroconversion. Their leukocytes produced abnormally high levels of I-IFN upon TLR7 stimulation with agonists or ssRNA viruses—particularly SARS-CoV-2—but not with DNA agonists of TLR9 or the dsDNA virus HSV-1. Moreover, the patients’ pDCs displayed cell-intrinsic hyperresponsiveness to TLR7 stimulation regardless of TLR7 levels. Inherited TLR7 or I-IFN deficiency confers a predisposition to life-threatening COVID-19. Conversely, our findings suggest that enhanced TLR7 activity in predisposed individuals could confer innate, pDC-mediated, sterilizing immunity to SARS-CoV-2 infection, with I-IFN–driven chilblains as a trade-off.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Interferon Type IChilblainsCOVID-19Dendritic CellsHumansSARS-CoV-2MaleFemaleAdultMiddle AgedPandemics

Substanzen

Toll-Like Receptor 7Interferon Type ITLR7 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, CHUV University Hospital and University of Lausanne, Lausanne, Switzerland.
  • St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.
  • Imagine Institute, Paris Cité University , Paris, France.
  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
  • Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

ORCID-Profile: Fanny Saidoune, Danyel Lee, Jeremy Di Domizio, Corentin Le Floc'h, Raphael Jenelten, Jérémie Le Pen, Vincent Bondet, Ana Joncic, Marie-Anne Morren, Vivien Béziat, Shen-Ying Zhang, Emmanuelle Jouanguy, Darragh Duffy, Charles M Rice, Curdin Conrad, Jacques Fellay, Jean-Laurent Casanova, Michel Gilliet, Ahmad Yatim

Förderung

  • European Academy of Dermatology and Venereology
  • Schlumberger Foundation
  • French Foundation for Medical Research
  • Université Paris-Saclay
  • Institut National de la Santé et de la Recherche Médicale
  • Carson Family Foundation
  • ITMO Cancer of Aviesan
  • NIAID NIH HHS

Zitieren

APA

Saidoune, F., Lee, D., Di Domizio, J., Le Floc'h, C., Jenelten, R., Le Pen, J., Bondet, V., Joncic, A., Morren, M. A., Béziat, V., Zhang, S. Y., Jouanguy, E., Duffy, D., Rice, C. M., Conrad, C., Fellay, J., Casanova, J. L., Gilliet, M., & Yatim, A. (2025). Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20231467

Vancouver

Saidoune F, Lee D, Di Domizio J, Le Floc'h C, Jenelten R, Le Pen J, et al. Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20231467

BibTeX
@article{Saidoune2025,
  author = {Saidoune, Fanny and Lee, Danyel and Di Domizio, Jeremy and Le Floc'h, Corentin and Jenelten, Raphael and Le Pen, Jérémie and Bondet, Vincent and Joncic, Ana and Morren, Marie-Anne and Béziat, Vivien and Zhang, Shen-Ying and Jouanguy, Emmanuelle and Duffy, Darragh and Rice, Charles M and Conrad, Curdin and Fellay, Jacques and Casanova, Jean-Laurent and Gilliet, Michel and Yatim, Ahmad},
  title = {Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20231467}
}
Kostenlos starten →